New breast cancer therapies based on available p38 MAPK inhibitors

Project Information

p38Cure

Grant agreement ID: 680908

DOI

10.3030/680908

Project closed

EC signature date 31 July 2015

Start date 1 October 2015

End date 31 March 2017

Funded under

• EXCELLENT SCIENCE - European Research Council (ERC)

Total cost

€ 149 995,00

EU contribution

€ 149 995,00

Coordinated by

FUNDACIO INSTITUT DE RECERCA BIOMEDICA (IRB BARCELONA)
Spain

CORDIS provides links to public deliverables and publications of HORIZON projects.

Links to deliverables and publications from FP7 projects, as well as links to some specific result types such as dataset and software, are dynamically retrieved from OpenAIRE .